Adherence To Current Guidelines For Chronic Obstructive Pulmonary Disease (COPD) In Subjects Treated With Combination Of Long-Acting Beta2-Agonist (LABA), Long-Acting Muscarinic Antagonist (LAMA) Or Inhaled Corticosteroids (ics)

被引：0
|
作者：
Asche, C. V.
Leader, S.
Plauschinat, C.
Raparla, S.
Yan, M.
Ye, X.
Young, D.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3115
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
    Ximena Rojas-Reyes, Maria
    Garcia Morales, Olga M.
    Dennis, Rodolfo J.
    Karner, Charlotta
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (06): : CD008532
  • [32] Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
    Karner, C.
    Cates, C. J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03):
  • [33] Time To Treatment Augmentation Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Newly Initiated On Long Acting Muscarinic Agents (lama) Or Inhaled Corticosteroid (ics) And Long Acting Beta-2 Agonist (laba) Combination Therapy
    Patel, J.
    Mapel, D. W.
    Roberts, M. H.
    Sama, S.
    Gilmore, J.
    Sundaresan, D.
    Laliberte, F.
    Pilon, D.
    Lefebvre, P.
    Duh, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Comparison of the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease
    Sarac, Pinar
    Sayiner, Abdullah
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [35] Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease
    Gershon, Andrea S.
    Campitelli, Michael A.
    Croxford, Ruth
    Stanbrook, Matthew B.
    To, Teresa
    Upshur, Ross
    Stephenson, Anne L.
    Stukel, Therese A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (11): : 1114 - 1121
  • [36] Compare the efficacy and safety of long-acting anticholinergic and a combination of inhaled steroids and long-acting beta-2 agonist in moderate chronic obstructive pulmonary disease
    Sarac, Pinar
    Sayiner, Abdullah
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (02): : 112 - 118
  • [37] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Eung Gu Lee
    Youlim Kim
    Yong Il Hwang
    Kwang Ha Yoo
    So Eun Lee
    Kyung Yoon Jung
    Doik Lee
    Yong Bum Park
    Chin Kook Rhee
    Scientific Reports, 13
  • [38] Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary disease
    Javier Nannini, Luis
    Lasserson, Toby J.
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
  • [39] Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
    Lee, Eung Gu
    Kim, Youlim
    Hwang, Yong Il
    Yoo, Kwang Ha
    Lee, So Eun
    Jung, Kyung Yoon
    Lee, Doik
    Park, Yong Bum
    Rhee, Chin Kook
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Mochizuki, Taichi
    Inoue, Yasushi
    Ueda, Ryuta
    Nagase, Seisuke
    Iwasaki, Kentarou
    Kojika, Masakazu
    Hayashi, Aeru
    RESPIROLOGY, 2018, 23 : 247 - 247
12345